PTEN and neoplasm: In addition to this, the MEred, MEblue, and MEbrown modules were also correlated with the tumor grade of the patient (MEred: adjusted P = 1e-25, r = –0.46; MEblue: adjusted P = 1e-10, r = 0.29; MEbrown: adjusted P = 2e-5, r = 0.2), Chr 7 gain/Chr 10 loss (MEred: adjusted P = 1e-20, r = –0.42; MEblue: adjusted P = 8e-61, r = 0.67; MEbrown: adjusted p = 0.006, r = 0.13), and PTEN mutation status (MEred: adjusted p = 0.003, r = –0.14; MEblue: adjusted P = 3e-8, r = 0.25; MEbrown: adjusted p = 0.03, r = 0.1) (Figure 2H).